EnglishSpanish

PRESS RELEASES

Blog

AstraZeneca agrees to distribute a potential Vaccine in EUROPE

AstraZeneca Plc (L:AZN) has signed a contract with European governments to supply the region with its potential vaccine against the coronavirus, the British drugmaker’s latest deal to pledge its drug to help combat the pandemic. The contract is for up to 400 million doses of the vaccine, developed by the University of Oxford, the company

Read More